Zobrazeno 1 - 5
of 5
pro vyhledávání: '"R A, Eusebio"'
Autor:
D Y, Mitchell, W H, Barr, R A, Eusebio, K A, Stevens, F P, Duke, D A, Russell, J D, Nesbitt, J H, Powell, G A, Thompson
Publikováno v:
Pharmaceutical research. 18(2)
To determine the pharmacokinetics and absolute bioavailability of risedronate after single-dose oral administration of 30 mg risedronate as a tablet and an aqueous solution, and 0.3 mg risedronate as an intravenous infusion.This study was a randomize
Autor:
D M, Reid, R A, Hughes, R F, Laan, N A, Sacco-Gibson, D H, Wenderoth, S, Adami, R A, Eusebio, J P, Devogelaer
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 15(6)
Long-term use of high-dose corticosteroids often results in bone loss, which may lead to osteoporosis-related fractures. This was a multicenter, double-blind study in which 290 ambulatory men and women receiving high-dose oral corticosteroid therapy
Publikováno v:
The Journal of clinical endocrinology and metabolism. 83(6)
Thirteen patients with severe Paget's disease of bone [mean serum alkaline phosphatase (SAP) level 17 times the upper limit of normal] were treated with 30 mg oral risedronate daily for 8 weeks. Patients were followed for 16 weeks without treatment.
Autor:
D Y, Mitchell, R A, Eusebio, L E, Dunlap, K A, Pallone, J D, Nesbitt, D A, Russell, M E, Clay, P J, Bekker
Publikováno v:
Pharmaceutical research. 15(2)
Two studies were conducted to compare the absorption of risedronate administered as a solution to three different gastrointestinal sites (study A) and to determine the extent of absorption of risedronate solution administered by rapid and slow infusi
Publikováno v:
Odontologia. 1(3)